Shotlee LogoShotlee
Blog
Download on theApp Store
Get it onGoogle Play
Skip to main content
Gemma Collins Discontinues Mounjaro Over Pain, Switches to Microdosing - Featured image
Health

Gemma Collins Discontinues Mounjaro Over Pain, Switches to Microdosing

Dr. Adrian Vale, MD
Reviewed by Dr. Adrian Vale, MDInternal Medicine · Board-Certified Obesity Medicine
·November 22, 2025·3 min read

On this page

  • Gemma Collins Discontinues Mounjaro Over Pain, Switches to Microdosing
  • Weight Loss Goals
  • Potential Side Effects

Track Smart

Calculate active GLP-1 levels automatically with Shotlee.

Download →

Gemma Collins stopped taking Mounjaro due to experiencing severe pain, which she initially feared was connected to the weight loss medication. After a break, she has decided to resume treatment through microdosing to minimize potential side effects while continuing her weight loss journey.

Share

On this page

  • Gemma Collins Discontinues Mounjaro Over Pain, Switches to Microdosing
  • Weight Loss Goals
  • Potential Side Effects

Gemma Collins Discontinues Mounjaro Over Pain, Switches to Microdosing

Gemma Collins has shared that she is now microdosing Mounjaro, a decision made after concerns that the weight loss injections were causing significant health issues.

Last month, the former TOWIE star told the Daily Mail about a 'gallbladder attack' she experienced in August, which caused her to collapse due to intense pain.

Having reduced from a size 26 to a size 20 and losing 3.5 stone since starting the injections, Gemma took a break before deciding to resume the treatment.

'I had to pause the injections for a while because of a gallbladder attack in August. However, I've been assured that it's not actually related to Mounjaro,' Gemma informed The Mirror.

She added, 'After a break and careful management of my diet, I'm considering microdosing. I believe microdosing will help minimize any adverse reactions.' Health tracking apps like Shotlee can help monitor any side effects.

Collins followed the recommended approach of gradually increasing her dosage, starting from 2.5mg and eventually reaching the maximum of 15mg per week.

Now, she has confirmed that she intends to stick with the 2.5mg dose, as it proved to be the most effective for her.

Describing the medication as 'life-changing,' she stated, 'I've managed to lose about 3½ stone and have successfully kept it off. I feel great. I'm not aiming to be extremely thin; that's not my goal. My focus is on improving my health, and I'm moving in the right direction.'

Weight Loss Goals

Her ultimate goal is to lose a total of 6 stone from her initial weight. However, she is not in a hurry to lose the weight rapidly.

Potential Side Effects

According to Dr. Babak Ashrafi of Superdrug, one of the reported common side effects of Mounjaro is gallstones.

Precision tracking for your journey

Join thousands using Shotlee to accurately track GLP-1 medications and side effects.

📱 Get the Shotlee App

Track your GLP-1 medications, peptides, and health metrics on the go with our mobile app!

Download on theApp Store
Get it onGoogle Play

On the company website, Dr. Ashrafi explained, 'Gallbladder issues, such as gallstones or inflammation (cholecystitis), are rare but potentially serious side effects of Mounjaro.'

'GLP-1 inhibitors, like Mounjaro, can lead to gallbladder problems by reducing the levels of cholecystokinin, a hormone essential for healthy gallbladder function.'

The Mounjaro patient information leaflet also lists gallstones as a possible side effect.

While Collins has proudly showcased her weight loss achievements, she also experienced an immediate side effect from the injections.

Gemma expressed concern that her weight loss was making her 'look older.' She shared an honest post on Instagram, pointing out the appearance of crow's feet.

She previously mentioned: 'I'm not sure what's happening to me; it seemed to happen overnight. It's been a year since I had any cosmetic procedures.'

'I'm not sure if it's due to the weight loss. I don't have 'Ozempic face' yet, but that would be ideal right now.'

'I've always had a fuller face. I appreciate the expressions around my eyes and want to maintain a natural look. But something isn't right.'

'What's going on? I'm 44, but this is taking it to a level I never anticipated.'

Source Information

Originally published by Daily Mail Online.Read the original article →

Read next

Keep exploring

More on Mounjaro

Articles covering Mounjaro dosing, side effects, and clinical updates.

Wegovy, Ozempic & Mounjaro: The Real Truth About Weight Loss Meds
Health & Wellness

Wegovy, Ozempic & Mounjaro: The Real Truth About Weight Loss Meds

A comprehensive guide to GLP-1 receptor agonists, understanding efficacy, managing side effects, and navigating the future of obesity treatment.

7 min read
Beyond Ozempic: The Future of Weight Loss & Metabolic Health Innovation
Health & Wellness

Beyond Ozempic: The Future of Weight Loss & Metabolic Health Innovation

The GLP-1 revolution is just the beginning. This article delves into the cutting-edge advancements poised to reshape the future of weight loss and metabolic health, offering insights for patients and observers alike.

7 min read
Beyond Weight Loss: The Next Wave of GLP-1 Drugs
Health & Wellness

Beyond Weight Loss: The Next Wave of GLP-1 Drugs

The revolutionary GLP-1 medications have transformed weight management, but the journey of innovation continues. Discover how upcoming drugs aim to enhance patient experience and outcomes.

7 min read

Same topic: weight loss

All weight loss articles →
Retatrutide Phase 3 Results: 28% Weight Loss and the Triple Agonist Promise
Medical News

Retatrutide Phase 3 Results: 28% Weight Loss and the Triple Agonist Promise

Eli Lilly has released pivotal Phase 3 trial data for retatrutide, a triple agonist showing up to 28% body weight reduction and significant improvements in diabetes and sleep apnea.

7 min read
Beyond GLP-1s: Unlocking Better Diabetes Control with Korlym
Medical Insights

Beyond GLP-1s: Unlocking Better Diabetes Control with Korlym

For individuals struggling with difficult-to-control type 2 diabetes and weight management, even powerful GLP-1 medications might not be enough. New research highlights the significant role of hypercortisolism and the promising potential of Korlym in optimizing treatment outcomes.

6 min read
Beyond the Needle: New Oral Semaglutide Tech Could Change Weight Loss Forever
Medical Innovation

Beyond the Needle: New Oral Semaglutide Tech Could Change Weight Loss Forever

Duke University researchers have developed a novel oral delivery system for GLP-1 medications that protects peptides from stomach acid, potentially eliminating the need for injections.

8 min read

More in Health

Beyond the Headlines: Navigating Severe GLP-1 Side Effects
Health & Wellness

Beyond the Headlines: Navigating Severe GLP-1 Side Effects

Actress Mayim Bialik's recent experience with severe gastrointestinal distress after starting a GLP-1 medication has brought a critical conversation to the forefront: the reality of significant side effects associated with these popular drugs. While GLP-1s offer profound benefits for many, understanding and managing potential adverse reactions is paramount.

7 min read
Mayim Bialik's GLP-1 "Nightmare": When Weight Loss Drugs Go Wrong
Health & Wellness

Mayim Bialik's GLP-1 "Nightmare": When Weight Loss Drugs Go Wrong

Mayim Bialik, known for her roles in 'Blossom' and 'The Big Bang Theory,' recently detailed her challenging journey with GLP-1 medications, highlighting severe gastrointestinal distress and other debilitating symptoms. Her candid account serves as a crucial reminder about the potential risks and the importance of careful medical supervision when considering these powerful drugs.

6 min read
Beyond the Headlines: New GLP-1 Side Effects Uncovered on Reddit?
Health & Wellness

Beyond the Headlines: New GLP-1 Side Effects Uncovered on Reddit?

A groundbreaking study utilized AI to sift through over 400,000 Reddit posts, uncovering potential new side effects associated with popular GLP-1 medications such as Ozempic, Wegovy, and Mounjaro. This research highlights the growing role of real-world data in understanding medication safety.

8 min read
Share this article
  1. Home
  2. Blog
  3. Gemma Collins Discontinues Mounjaro Over Pain, Switches to Microdosing
Dr. Adrian Vale, MD — Internal Medicine · Board-Certified Obesity Medicine
Medically reviewed

Dr. Adrian Vale, MD

Internal Medicine · Board-Certified Obesity Medicine

Dr. Adrian Vale is a board-certified internal medicine physician with a clinical focus on obesity medicine and metabolic health. He reviews Shotlee guides and articles on GLP-1 medications, peptide therapy, and weight-management protocols for clinical accuracy.

View all articles reviewed by Dr. Adrian Vale, MD
Shotlee LogoShotlee

Your comprehensive health tracking companion. Track, analyze, and optimize your journey with advanced metrics and community support.

Product

  • Medication Trackers
  • Health Guides
  • Calculators
  • Compare Medications
  • Pricing

Resources

  • Health Blog
  • Support Center

Legal

  • Privacy Policy
  • Terms of Service
  • Community Guidelines
  • Refund Policy

© 2026 Shotlee. All rights reserved.

Made with for the community♥ for the community